Drupal-Bibcite17<style face="normal" font="default" size="100%">N-acetylcysteine reduces disease activity by blocking mammalian target of rapamycin in T cells from systemic lupus erythematosus patients: a randomized, double-blind, placebo-controlled trial</style>